You’ve been prescribed MENOPUR®, the only gonadotropin approved by the FDA on the basis of pregnancy rates. MENOPUR® is the most widely used and extensively studied reproductive hormone, proven to be both safe and effective.
As part of an Assisted Reproductive Technology (ART) program, MENOPUR® is administered by subcutaneous (SC) injection only and is used to induce the development of multiple eggs and pregnancy in women who are able to produce and release eggs (ovulate). Its unique purity is also associated with less discomfort at the injection site, an important point for many women.
About MENOPUR®
MENOPUR® is a highly purified preparation of naturally derived gonadotropins, called hMG. MENOPUR® contains equal amounts (75 IUs) of 2 kinds of hormonal activity: follicle-stimulating hormone (FSH), which helps stimulate egg production; and luteinizing hormone (LH), which helps the eggs mature and release (ovulate). MENOPUR® helps stimulate eggs to mature in women whose ovaries are basically healthy but are unable to develop eggs. It is not used for women who suffer from ovarian failure.
MENOPUR® is usually used together with human chorionic gonadotropin (hCG), and is indicated for the development of multiple follicles and pregnancy in women participating in an Assisted Reproductive Technology (ART) program.
In an IVF trial of over 700 women, the efficacy and safety of MENOPUR® was compared to a previously available treatment, recombinant FSH. While prior treatments had been approved on the basis of number of oocytes (eggs), due to the results of this study, MENOPUR® became the first and only gonadotropin treatment approved by the FDA on the basis of pregnancy rates, the true measure of clinical effectiveness.2
Other clinical studies have shown that treatment with MENOPUR® was shown to have a significant impact on the quality of the developing embryo, and to significantly impact pregnancy and birth rates.3-5
MENOPUR® is available by prescription in 5 mL vials containing 75 IU FSH and 75 IU LH activity with accompanying diluent.
Q•Cap™ is the only available vial adapter for needle-free reconstitution. Q•Cap™ eliminates stress, anxiety, and accidental needlesticks associated with traditional reconstitution, which increases your comfort level and that of your partner. And, importantly, Q•Cap™ helps build your confidence about reconstitution.
Q•Cap™ can only be used with Ferring fertility products, including BRAVELLE®, MENOPUR®, and REPRONEX®.
MENOPUR® administered subcutaneously is indicated for the development of multiple follicles and pregnancy in the ovulatory patients participating in an ART program.
